Ultime notizie per Rekor Systems (NASDAQ:REKR) Azioni

Rekor Systems

Rekor Systems Inc is a United States-based company. The company is engaged in providing real-time roadway intelligence through AI-driven decisions. The firm uses artificial intelligence to analyze video streams and transform them into AI-driven decisions. The company's technology and machine learning models power all solutions, including Rekor Command for transportation management, Rekor Discover for urban mobility, and Rekor Scout for public safety, and commercial use. Its geographical segments are the United States and Others, of which a majority of its revenue comes from the United States.

Long Ideas

News

Markets

Media

Trading Ideas

CHRD

LRCX

REKR

SOUN

Jim Cramer mette in guardia dai titoli meme e indica un&#39;opportunità nel settore tecnologico. Analisi delle sue raccomandazioni.

Jim Cramer: non consiglio titoli meme, meglio questo titolo tecnologico

Rekor Systems Inc

Rekor Systems Inc Warrants(08/11/2023)

<ul>
<li>Sigma Lithium continued to demonstrate its operational resilience delivering strong financial performance:
<ul>
<li>Production of 68,308t of lithium oxide, above target and 26% higher than 1Q24.</li>
<li>CIF China Cash Costs and All-In Sustaining Costs: US$458/t and US$622/t, respectively 8% and 6% better than FY 2025 targets.</li>
<li>EBITDA and adjusted EBITDA for non-cash expenses: US$10m and US$11.4m, respectively, representing 21% and 24% EBITDA margins; and a significant 28% increase in revenues compared to 1Q24. &nbsp;</li>
</ul>
</li>
<li>The Company was truly honored by the overwhelming positive endorsement received from our communities at Vale do&nbsp;Jequitinhonha, demonstrated by over 2,000 supporters during the public hearings on lithium production at Brazil's Lithium Valley:
<ul>
<li>An unprecedented 91% of favorable depositions and testimonials from the residents of cities&nbsp;Itinga and Araçuaí. &nbsp;</li>
</ul>
</li>
<li>We are also proud to be able to count on the unequivocal support of Brazil's Federal Government and of&nbsp;Minas Gerais State Government:
<ul>
<li>Sigma Lithium has become a locomotive of prosperity in the region, creating over 1,700 direct and 20,000 indirect jobs with more than 21,000 people benefiting from our social inclusion programs of&nbsp;microcredit and irrigation for subsistence family agriculture.</li>
</ul>
</li>
</ul>

SGML

Reported Earlier, Sigma Lithium Q1 Preview: Outperforms 1Q25 Targets With 26% Higher Production, 28% Revenue Growth, and Strong 24% EBITDA Margin Despite Weaker Lithium Prices

Adtran Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADTN#NASDAQ">ADTN</a>) sees Q2 sales of $247.500 million-$262.500 million vs $263.49 million analyst estimate.

Guidance

ADTN

Adtran Holdings Sees Q2 Sales $247.500M-$262.500M vs $263.49M Est

Adtran (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADTN#NASDAQ">ADTN</a>) reported quarterly earnings of $0.03 per share which missed the analyst consensus estimate of $0.04 by 25 percent. This is a 250 percent increase over losses of $(0.02) per share from the same period last year. The company reported quarterly sales of $247.74 million which missed the analyst consensus estimate of $255.07 million by 2.87 percent. This is a 9.54 percent increase over sales of $226.17 million the same period last year.

Earnings

Earnings Misses

Adtran Q1 Adj. EPS $0.03 Misses $0.04 Estimate, Sales $247.74M Miss $255.07M Estimate

BlackBerry Expands Cybersecurity Skill Development At Malaysia CCoE With EC Council Learning Platform And Flexible Online, In-Person Training Options

The Walt Disney Co.&#8216;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>) domestic theme parks are delivering excellent returns on investment, providing strong validation for the company&#8217;s $30 billion capital expenditure plan despite prevailing macroeconomic concerns.
What Happened: This stellar performance within the Experiences segment was a key highlight of <a href="https://www.benzinga.com/general/travel/25/05/45260938/disneys-new-abu-dhabi-theme-park-will-be-authentically-disney-and-distinctly-emirati-ceo-bob-iger-says">Disney&#8217;s second-quarter 2025 earnings</a>, contributing significantly to the company exceeding overall financial expectations and fueling over a 10% rally in its stock price on Wednesday.
CEO Bob Iger said the &#8220;outstanding performance from our domestic businesses&#8221; within the Experiences division, noting that investments in this segment have achieved &#8220;all time highs&#8221; in terms of returns. 
This robust profitability underscores the effectiveness of Disney&#8217;s strategy to enhance its theme parks in Florida and California. The $30 billion investment initiative is aimed at not only upgrading offerings and creating employment but also strategically increasing park capacity to accommodate more guests without compromising the visitor experience, according to Iger. &nbsp;
See Also: <a href="https://www.benzinga.com/markets/25/05/45274831/trump-tariff-pressure-reportedly-opens-global-doors-for-elon-musks-starlink-as-nations-rush-to-show-goodwill">Trump Tariff Pressure Reportedly Opens Global Doors For Elon Musk&#8217;s Starlink As Nations Rush To Show &#8216;Goodwill&#8217;</a>
Why It Matters: The strong performance of the domestic parks played a crucial role in Disney surpassing analyst projections for both earnings per share and <a href="https://www.benzinga.com/general/travel/25/05/45260938/disneys-new-abu-dhabi-theme-park-will-be-authentically-disney-and-distinctly-emirati-ceo-bob-iger-says">revenue in the second quarter</a>. 
This positive momentum allowed the company to raise its full-year earnings per share guidance, signaling management&#8217;s confidence in the continued strength of this segment and its ability to navigate potential economic headwinds. Forward-looking indicators for the domestic parks remain positive, with bookings for Walt Disney World showing increases of 4% and 7% for the third and fourth quarters, respectively. &nbsp;
While Disney is also pursuing growth <a href="https://www.benzinga.com/general/travel/25/05/45260938/disneys-new-abu-dhabi-theme-park-will-be-authentically-disney-and-distinctly-emirati-ceo-bob-iger-says">through international expansions</a>, such as the upcoming theme park in Abu Dhabi, the current record returns from its domestic parks underscore the enduring appeal and profitability of its core theme park business in the United States. 
Price Action: On Wednesday, Disney&#8217;s stock price reflected positive sentiment, closing up by 10.86%, trading at $102.09, although it remains down 7.88% year-to-date, according to <a href="https://pro.benzinga.com/dashboard">data from Benzinga Pro</a>.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/05/45275248/uber-ceo-dara-khosrowshahi-says-average-waymo-in-austin-is-busier-than-99-of-human-drivers">Uber CEO Dara Khosrowshahi Says &#8216;Average Waymo In Austin Is Busier Than 99%&#8217; Of Human Drivers</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Jerome LABOUYRIE / Shutterstock.com

Equities

Disney's $30 Billion Theme Park Bet Pays Off As Bob Iger Touts 'All-Time High' Returns, Stock Rallies 10% After Q2 Earnings

Shopify Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHOP#NASDAQ">SHOP</a>) will release earnings results for the first quarter, before the opening <a href="https://www.benzinga.com/quote/SHOP/earnings">bell on Thursday, May 8</a>.
Analysts expect the Ottawa, Canada-based company to report quarterly earnings at 26 cents per share, up from 20 cents per share in the year-ago period. Shopify projects to report quarterly revenue at $2.33 billion, compared to $1.86 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Affirm Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>) and Shopify announced on April 9 that they are accelerating their global expansion plans.
Shopify shares rose 0.7% to close at $94.50 on Wednesday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/shop/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>Truist Securities analyst Terry Tillman maintained a Hold rating and cut the price target from $120 to $100 on May 6, 2025. This analyst has an accuracy rate of 61%.</li>
<li>Benchmark analyst Mark Zgutowicz maintained a Buy rating and cut the price target from $150 to $125 on May 6, 2025. This analyst has an accuracy rate of 62%.</li>
<li>BMO Capital analyst Thomas Moschopoulos initiated coverage on the stock with an Outperform rating and a price target of $120 on May 6, 2025. This analyst has an accuracy rate of 75%.</li>
<li>Oppenheimer analyst Ken Wong maintained an Outperform rating and slashed the price target from $150 to $125 on April 30, 2025. This analyst has an accuracy rate of 73%.</li>
<li>Keybanc analyst Philip Gibbs maintained an Overweight rating and cut the price target from $140 to $105 on April 23, 2025. This analyst has an accuracy rate of 84%.</li>
</ul>
Considering buying SHOP stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="566" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/08022941/image-77-1024x566.png" alt="" class="wp-image-907133" style="width:623px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/08022941/image-77-1024x566.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/08022941/image-77-300x166.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/08022941/image-77-768x424.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/08022941/image-77.png 1126w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/05/45250672/wall-streets-most-accurate-analysts-give-their-take-on-3-industrials-stocks-delivering-high-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Industrials Stocks Delivering High-Dividend Yields</a></li>
</ul>
Photo via Shutterstock

Price Target

Pre-Market Outlook

Analyst Ratings

AFRM

SHOP

Shopify Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

David Bailey, CEO of Bitcoin Magazine and cryptocurrency advisor to President Donald Trump, raised $300 million to create a publicly traded Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) investment company, according to a report on Wednesday.
What Happened: The fundraising effort, which began in January, includes&nbsp;$200 million in equity funding&nbsp;and $100 million in convertible&nbsp;debt, CNBC <a href="https://www.cnbc.com/2025/05/07/trump-crypto-advisor-david-bailey-300-million-bitcoin-investment-co.html">reported</a>, citing sources familiar with the matter.
The new company, named&nbsp;Nakamoto&nbsp;in honor of&nbsp;the pseudonymous creator Satoshi&nbsp;Nakamoto,&nbsp;will focus on acquiring and&nbsp;holding Bitcoin. Nakamoto is expected&nbsp;to merge with an existing&nbsp;Nasdaq-listed company, with an announcement likely to be made early next week.
See Also:&nbsp;<a href="https://benzinga.com/trading-ideas/movers/25/05/45274508/bitcoin-taps-98000-ethereum-dogecoin-steady-as-fed-chair-jerome-powell-raises-trump-tariff-induced-concerns-analyst-says-eth-holding-above-crucial-level-and-begins-its" target="_blank" rel="noreferrer noopener">Bitcoin Taps $98,000, Ethereum, Dogecoin Steady As Fed Chair Jerome Powell Raises Trump Tariff-Induced Concerns: Analyst Says ETH Holding Above &#8216;Crucial Level&#8217; And Begins Its &#8216;Bounce Upwards&#8217;</a>
Nakamoto&#8217;s public listing is slated for this summer. The company plans to acquire businesses worldwide, including in Brazil, Thailand,&nbsp;and South Africa, and invest&nbsp;its bitcoin into them, the report mentioned. 
Interestingly, Bailey shared a cryptic post, hinting at a future in which the equivalent of Strategy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) would be available in different countries. &#8220;This play is just getting started,&#8221; he wrote.
Bailey didn&#8217;t immediately return Benzinga&#8217;s request for confirmation.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Anybody want to invest in the: MicroStrategy of Saudi Arabia? MicroStrategy of Turkey? MicroStrategy of South Korea? MicroStrategy of South Africa? This play is just getting started
&mdash; David Bailey&#x1f1f5;&#x1f1f7; $1.0mm/btc is the floor (@DavidFBailey) <a href="https://twitter.com/DavidFBailey/status/1920339637635031209?ref_src=twsrc%5Etfw">May 8, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Why It Matters: This development follows Bailey&#8217;s <a href="https://www.benzinga.com/markets/cryptocurrency/24/08/40567193/trumps-bitcoin-turnaround-caused-by-100m-influence-from-a-trio-of-puerto-rican-advocates-r">influential role in shaping Trump&#8217;s stance on Bitcoin</a>. Bailey, along with Bitcoin mining expert Amanda Fabiano and former California prosecutor Tracy Hoyos-López, successfully convinced Trump about Bitcoin's potential, leading to his embrace of the apex cryptocurrency.
Trump&nbsp;pushed for a <a href="https://www.benzinga.com/25/03/44183572/trump-establishes-strategic-bitcoin-reserve-funded-by-forfeited-assets-i-made-the-promise">strategic national Bitcoin stockpile</a>&nbsp;on the campaign trail and ended up creating one after assuming office
Price Action:  At the time of writing, Bitcoin was exchanging hands at $98,927.66, up 2.61% in the last 24 hours, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA..">data from Benzinga Pro</a>. 
Photo Courtesy: Mc_Cloud on Shutterstock.com
Read Next:&nbsp;
<ul>
<li><a href="https://benzinga.com/markets/cryptocurrency/25/05/45233324/dogecoin-teases-diamond-bottom-reversal-is-a-breakout-imminent" target="_blank" rel="noreferrer noopener">Dogecoin Teases &#8216;Diamond Bottom&#8217; Reversal: Is A Breakout Imminent?</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.<a href="https://www.benzinga.com/apis?utm_source=benzinga.com&amp;utm_campaign=article-bottom" rel="noreferrer noopener" target="_blank"></a>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

MSTR

Trump Crypto Advisor Rakes In $300 Million For Bitcoin Investment Company That Hopes To Bring MSTR Model To The World

Concurrently with the proposed upsized public offering, the Company intends to complete a private placement of 17,173,853 common shares to certain of its major shareholders at the public offering price. NOVAGOLD intends to use the net proceeds from the offering and the concurrent private placement described above to fund the purchase price for NOVAGOLD's previously announced acquisition1 of an additional 10% ownership interest in Donlin Gold LLC and to use the remaining net proceeds, if any, for general corporate purposes including updating the feasibility study.

NOVAGOLD Prices $179M Underwritten Upsized Public Offering Of 47.85M Common Shares At $3.75 Per Share

Macro Economic Events

Econ #s

Economics

Germany Trade Balance For March 21.1B Vs. 19.0B Est.; 17.7B Prior

Germany Industrial Production (MoM) For March 3.0% Vs. 0.9% Est.; -1.3% Prior

U.K. Halifax House Price Index (MoM) For April 0.3% Vs. 0.2% Est.; -0.5% Prior

U.K. Halifax House Price Index (YoY) For April 3.2% Vs. 2.6% Est.; 2.9% (Revised) Prior

Equinox Gold (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/EQX#AMEX">EQX</a>) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of $0.15 by 153.33 percent. This is a 100 percent decrease over losses of $(0.04) per share from the same period last year. The company reported quarterly sales of $423.70 million which missed the analyst consensus estimate of $434.00 million by 2.37 percent. This is a 75.59 percent increase over sales of $241.30 million the same period last year.

Equinox Gold Q1 Adj. EPS $(0.08) Misses $0.15 Estimate, Sales $423.70M Miss $434.00M Estimate

FINANCIAL GUIDANCE
The financial guidance on the combined selling, general and administrative expenses and research and development expenses remains unchanged at approximately $2.5 billion.

ARGX

argenx Maintains FY25 Financial Guidance With $2.5B Target For Combined SG&A And R&D Expenses

For 2025, the Company anticipates: &nbsp;
<ul>
<li>Total revenues between US$325 million and US$340 million (9% to 14% growth), with quarterly fluctuations expected.</li>
<li>Total operating expenses not to exceed the prior year pre-Abliva impact and we expect US$30 million in Abliva-related operating expenses, including research and development and non-recurring transaction and integration expenses.</li>
<li>Significant progress finding additional APDS patients in the U.S., supported by VUS validation efforts and subsequently converting patients to paid Joenja&#xAE; (leniolisib) therapy.</li>
<li>Increasing ex-U.S. revenues for leniolisib - driven by funded access programs and commercial availability in the U.K.</li>
<li>Progress towards additional regulatory approvals for leniolisib for APDS patients 12 years of age or older, and submitting regulatory filings in Japan and for pediatric label expansion in key global markets.</li>
<li>Advancing the two ongoing Phase II clinical trials in PIDs with immune dysregulation to significantly expand the long-term commercial potential of leniolisib.</li>
<li>Advancing the ongoing pivotal FALCON clinical study for KL1333 in mitochondrial DNA-driven primary mitochondrial diseases.</li>
<li>Continued focus on potential acquisitions and in-licensing of clinical stage opportunities in rare diseases.</li>
</ul>
No further specific financial guidance for 2025 is provided.

PHAR

Pharming Group 2025 Raises Total Revenue Guidance To $325M-$340M (Prior $315M-$335M) vs. $324.3M Est.

Tony Fadell, the iPod inventor who later sold smart-home pioneer Nest to Google (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>), says Silicon Valley's plush perks can quietly smother urgency and innovation.
What Happened: "At Apple (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), you couldn't hide," he told the <a href="https://www.youtube.com/watch?v=I-8NdMx-g60">audience</a> at TechCrunch Disrupt 2024. "Everyone was critical."
That rigor vanished when he joined Google after the $3.2 billion Nest deal. "You were lucky if they even showed up… They'd take the bus in for lunch, get a massage, grab yogurt, and head home," Fadell said, blasting the search giant's famed "20 percent time" that lets engineers <a href="https://www.benzinga.com/general/entrepreneurship/17/11/10265560/what-i-learned-from-reading-every-google-founders-letter">pursue side projects</a>.
Such freedom, he warned, breeds "mediocrity" that startups can't afford. "It will mess up your culture" if you hire 15-year "career Googlers," he added.
See also: <a href="https://www.benzinga.com/25/05/45275079/bob-iger-admits-marvel-lost-focus-by-making-too-much-content-saying-quantity-does-not-necessarily-beget-quality-heres-what-disney-plans-to-do-now">Bob Iger Admits Marvel Lost Focus By Making Too Much Content, Saying &#8216;Quantity Does Not Necessarily Beget Quality&#8217; — Here&#8217;s What Disney Plans To Do Now</a>
Fadell's culture-first mantra traces back to General Magic in the 1990s, where <a href="https://www.benzinga.com/news/24/10/41616573/ipod-co-creator-tony-fadell-dismisses-chatgpt-type-llms-saying-were-trying-to-make-science-fiction-h">executives vowed</a> never to bring in "East Coast" talent that demanded drivers and executive toilets — benefits he now sees everywhere in tech. Padell has previously publicly decried the Valley's "entitlement" and said comfort can "kill the hustle" needed for deep-tech breakthroughs.
What To Know: The Nest-Google marriage offers a cautionary case study. According to a <a href="https://www.newyorker.com/business/currency/tony-fadell-nest-and-the-failure-of-a-middle-ground">report</a> by the New Yorker, analysts noted the hardware startup chafed under Google's looser, bottom-up structure, a clash that hastened Fadell's 2016 exit and forced Alphabet to rethink its tech ambitions.
Management experts say Apple's top-down accountability — memorialized in Harvard Business Review <a href="https://www.apple.com/jobs/pdf/HBR_How_Apple_Is_Organized_For_Innovation-4.pdf">papers</a> — shows how tight oversight can scale creativity without free-rider risk.
Fadell's bottom line for founders: don't confuse beanbags for productivity. "Entitlement everywhere" is today's biggest silent cost, he argued, one that no valuation, wellness stipend or kombucha tap can paper over.
Photo Courtesy: Tada Images On Shutterstock.com
Read next: <a href="https://www.benzinga.com/markets/equities/25/05/45275248/uber-ceo-dara-khosrowshahi-says-average-waymo-in-austin-is-busier-than-99-of-human-drivers">Uber CEO Dara Khosrowshahi Says &#8216;Average Waymo In Austin Is Busier Than 99%&#8217; Of Human Drivers</a>

Tech

AAPL

GOOGL

iPod Creator Says Apple's Hard-Edged Work Culture Beats Google's 'Take The Bus In For Lunch, Grab Yogurt, And Head Home' Lifestyle

2025 Outlook
(i) Overall Performance: We expect our EBITDA to grow in line with our medium-term outlook of between 4-8%. The outlook for FY25 reflects our current assessment of inflation and other macroeconomic conditions.
(ii) Net Finance Costs: Net pension interest expenses and accretion expenses are expected to be in the range of 190 to 220 million USD per quarter, depending on currency and interest rate fluctuations. We expect the average gross debt coupon in FY25 to be approximately 4%.
(iii) Effective Tax Rate (ETR): We expect the normalized ETR in FY25 to be in the range of 26% to 28%. The ETR outlook does not consider the impact of potential future changes in legislation.
(iv) Net Capital Expenditure: We expect net capital expenditure of between 3.5 and 4.0 billion USD in FY25.

AB InBev Expects FY25 EBITDA Growth Of 4-8% Amid Stable Macro Outlook, Targets $3.5B–4BIn Net Capital Expenditure

OpenAI is reportedly negotiating with a senior technology executive to take on a major leadership role.
What Happened: OpenAI is in talks to bring in a senior tech executive to oversee several of the company's divisions, reported Reuters (<a href="https://www.theinformation.com/articles/openai-talks-hire-senior-executive-major-leadership-role">via</a> The Information).
The move is part of a larger leadership shake-up at the artificial intelligence firm, sources familiar with the matter told the publication.
See Also:&nbsp;<a href="https://benzinga.com/news/25/04/45090231/elon-musk-says-will-come-as-a-surprise-to-most-as-chinas-economy-surpasses-us-and-eu-amid-rising-tariffs-and" target="_blank" rel="noreferrer noopener">Elon Musk Says Will Come As A ‘Surprise To Most&#8217; As China&#8217;s Economy Surpasses US And EU Amid Rising Tariffs And Growing Recession Fears</a>
While OpenAI CEO Sam Altman is expected to continue leading the company's research and infrastructure teams — the critical units driving AI development — much of the rest of the organization would fall under the supervision of the new executive, the report said.
OpenAI did not immediately respond to <a href="https://pro.benzinga.com/dashboard">Benzinga's</a> request for comments.
Why It's Important: Earlier this week, it was reported that OpenAI has told investors it plans to <a href="https://www.benzinga.com/25/05/45244190/microsoft-faces-fresh-revenue-hit-as-openai-plans-to-reduce-payouts-by-2030-report">decrease the share of revenue</a> it allocates to Microsoft Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>).
The report surfaced after it was announced that OpenAI&#8217;s nonprofit parent organization will <a href="https://www.benzinga.com/markets/25/05/45213089/openai-reverses-course-as-sam-altman-says-nonprofit-will-remain-in-control-amid-elon-musks-lawsuit-and-investor-pushback">maintain control</a> of the company.
Photo Courtesy: Primakov On Shutterstock.com
Read Next:
<ul>
<li><a href="https://benzinga.com/25/04/45071155/mild-recession-is-best-case-outcome-jpmorgan-ceo-jamie-dimon" target="_blank" rel="noreferrer noopener">JPMorgan CEO Jamie Dimon Warns Recession Is Best-Case Outcome Of Trump Trade War</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

MSFT

OpenAI Reportedly Reshaping Leadership, Taps Senior Executive To Run Divisions Beyond Sam Altman's AI Focus

Novo Nordisk A/S (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) is seeking FDA approval for the pill version of its obesity drug, Wegovy. The company recently highlighted early data that shows safety and efficacy figures that are similar to its injectables.
What Happened: On Wednesday, during Novo&#8217;s <a href="https://benzinga.com/25/05/45252150/novo-nordisk-expects-fda-decision-for-oral-wegovy-by-end-of-2025-reports-mixed-q1-earnings">first quarter earnings</a> call, the company highlighted its upcoming oral weight loss drug, which CEO Lars Fruergaard calls &#8220;Wegovy in a pill,&#8221; and is currently under review by the U.S. Food and Drug Administration.
&#8220;If approved, this will be the first oral GLP-1 treatment for obesity in the United States,&#8221; Fruergaard said, adding that being first to market with a &#8220;known molecule, known efficacy, known safety&#8221; positions the company well in what he described as a smaller, but meaningful, segment of the market.
See More: <a href="https://www.benzinga.com/markets/equities/25/05/45275248/uber-ceo-dara-khosrowshahi-says-average-waymo-in-austin-is-busier-than-99-of-human-drivers">Uber CEO Dara Khosrowshahi Says &#8216;Average Waymo In Austin Is Busier Than 99%&#8217; Of Human Drivers</a>
Martin Lange, executive vice president of development at Novo, said the 25-milligram oral formulation &#8220;demonstrates an overall efficacy and safety profile similar to once-weekly injectable semaglutide 2.4 milligram.&#8221;
During the trial, adults struggling with obesity, who received 25 milligrams of oral semaglutide experienced &#8220;16.6% average weight loss,&#8221; Lange says, with one-third of participants experiencing weight loss of &#8220;20% of more.&#8221; Lange added that the FDA review is expected to conclude by late 2025 or early 2026.
Why It Matters: The company saw a <a href="https://benzinga.com/25/05/45252150/novo-nordisk-expects-fda-decision-for-oral-wegovy-by-end-of-2025-reports-mixed-q1-earnings">big surge in Wegovy sales</a> during the first quarter, at $2.63 billion, up 85% year-over-year, as it gears up to launch the oral version of its drug.
This comes amid analyst predictions that rival Eli Lilly And Co.&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) oral weight loss drugs can <a href="https://www.benzinga.com/general/biotech/25/04/44934811/eli-lilly-positioned-to-dominate-obesity-market-with-oral-option-analyst-initiates-with-confidence">take share away</a> from Novo&#8217;s Semaglutide. 
During its first quarter, Novo Nordisk generated $10.9 billion in sales, missing consensus estimates at $11.64 billion, with a profit of $0.92 per share, beating estimates at $0.90. 
Price Action: The stock was up 1.90% on Wednesday, but is down 2.38% after hours following the company&#8217;s first quarter earnings release.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="137" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/08011053/Screenshot-2025-05-08-at-10.40.38-AM-1024x137.png" alt="" class="wp-image-907057" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/08011053/Screenshot-2025-05-08-at-10.40.38-AM-1024x137.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/08011053/Screenshot-2025-05-08-at-10.40.38-AM-300x40.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/08011053/Screenshot-2025-05-08-at-10.40.38-AM-768x103.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/08011053/Screenshot-2025-05-08-at-10.40.38-AM-1536x205.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/08011053/Screenshot-2025-05-08-at-10.40.38-AM.png 1588w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
According to Benzinga Edge Stock Rankings, Novo Nordisk has an unfavorable price trend in the short, medium, and long term. For more insights, sign up for <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">Benzinga Edge</a>.
Photo Courtesy: kikpokemon on Shutterstock.com
Read More: <a href="https://www.benzinga.com/markets/25/05/45274831/trump-tariff-pressure-reportedly-opens-global-doors-for-elon-musks-starlink-as-nations-rush-to-show-goodwill">Trump Tariff Pressure Reportedly Opens Global Doors For Elon Musk&#8217;s Starlink As Nations Rush To Show &#8216;Goodwill&#8217;</a>

Health Care

Novo Nordisk Says Its 'Wegovy In A Pill' Delivers Big: '16.6% Average' Weight Loss, Over 20% For One-Third Of Adults Struggling With Obesity

Pharming (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHAR#NASDAQ">PHAR</a>) reported quarterly sales of $79.10 million which beat the analyst consensus estimate of $67.73 million by 16.78 percent. This is a 42.30 percent increase over sales of $55.59 million the same period last year.

Pharming Q1 Sales $79.10M Beat $67.73M Estimate, Adj. Net Loss $7.1M

Press Releases

Rekor Systems Taps SoundHound AI to Revolutionize Emergency Vehicle Technology With First Of Its Kind Audio-Visual AI

Rekor Scout® Certified for New Jersey's $13M Public Safety Initiative, Empowering Law Enforcement with Advanced Technology

Rekor Systems Secures European Patent for Advanced Technology to Detect and Mitigate Irregular Traffic Congestion

Rekor Systems to Participate in the 37th Annual Roth Conference

Rekor Systems to Announce 2024 Results

Rekor's Vehicle Insite Application Deployed to Study Electric Vehicle Movement Across 90 Sites in the Phoenix Metropolitan Area

Rekor Systems Provides Guidance on Financial Results and Updates on Operational and Management Realignments

Rekor Systems Reports Strong 2024 Financial Results Highlighted by Record Revenue and Significant Operational Improvements

General

SoundThinking Enhances PlateRanger Investigative Capabilities with Integrations into SafetySmart Platform and Partner Technologies, Providing a 'Force Multiplier'

Rekor Systems to Announce First Quarter Fiscal 2025 Results

SSTI

AudioEye

Arqit Quantum

CoreCard

Cheetah Mobile Inc. American Depositary Shares, each representing fifty (50) Class A Ordinary Shares

Comments

Rekor Systems

Notizie

Ultime notizie per Rekor Systems (NASDAQ:REKR) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO